Home Healthcare Biotechnology Antimicrobial Resistance Diagnostics Market

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microbial Culture, Immunoassay, Polymerase Chain Reaction, Next-generation Sequencing, Mass Spectrometry, Others), By Pathogen (Methicillin-Resistant Staphylococcus Aureus, Drug-Resistant Streptococcus Pneumoniae, Drug-Resistant Campylobacter, Drug-Resistant Neisseria Gonorrhea, Drug-Resistant Salmonella, Others), By End Use (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: January 13, 2026 | Author: Debashree B | Format: | Report Code: SR7751DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Antimicrobial Resistance Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Microbial Culture
    2. Immunoassay
    3. Polymerase Chain Reaction
    4. Next-generation Sequencing
    5. Mass Spectrometry
    6. Others
  2. Antimicrobial Resistance Diagnostics Market, By Pathogen 2022-2034 (USD MILLION/ Units)
    1. Methicillin-Resistant Staphylococcus Aureus 
    2. Drug-Resistant Streptococcus Pneumoniae
    3. Drug-Resistant Campylobacter
    4. Drug-Resistant Neisseria Gonorrhea
    5. Drug-Resistant Salmonella
    6. Others
  3. Antimicrobial Resistance Diagnostics Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Laboratories
    3. Pharmaceutical & Biotechnology Companies
    4. Others
  4. Regional Antimicrobial Resistance Diagnostics Market
    1. North America
      1. North America Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      2. North America Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      3. North America Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
      4. U.S. Antimicrobial Resistance Diagnostics Market
        1. U.S. Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. U.S. Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. U.S. Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      5. Canada Antimicrobial Resistance Diagnostics Market
        1. Canada Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Canada Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Canada Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
    2. Europe
      1. Europe Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      2. Europe Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      3. Europe Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
      4. U.K. Antimicrobial Resistance Diagnostics Market
        1. U.K. Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. U.K. Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. U.K. Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      5. Germany Antimicrobial Resistance Diagnostics Market
        1. Germany Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Germany Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Germany Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      6. France Antimicrobial Resistance Diagnostics Market
        1. France Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. France Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. France Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      7. Spain Antimicrobial Resistance Diagnostics Market
        1. Spain Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Spain Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Spain Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      8. Italy Antimicrobial Resistance Diagnostics Market
        1. Italy Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Italy Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Italy Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      9. Russia Antimicrobial Resistance Diagnostics Market
        1. Russia Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Russia Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Russia Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      10. Nordic Antimicrobial Resistance Diagnostics Market
        1. Nordic Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Nordic Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Nordic Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      11. Benelux Antimicrobial Resistance Diagnostics Market
        1. Benelux Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Benelux Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Benelux Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      12. Rest of Europe Antimicrobial Resistance Diagnostics Market
        1. Rest of Europe Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Rest of Europe Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Rest of Europe Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
    3. APAC
      1. APAC Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      2. APAC Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      3. APAC Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
      4. China Antimicrobial Resistance Diagnostics Market
        1. China Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. China Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. China Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      5. Korea Antimicrobial Resistance Diagnostics Market
        1. Korea Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Korea Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Korea Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      6. Japan Antimicrobial Resistance Diagnostics Market
        1. Japan Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Japan Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Japan Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      7. India Antimicrobial Resistance Diagnostics Market
        1. India Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. India Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. India Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      8. Australia Antimicrobial Resistance Diagnostics Market
        1. Australia Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Australia Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Australia Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      9. Taiwan Antimicrobial Resistance Diagnostics Market
        1. Taiwan Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Taiwan Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Taiwan Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      10. South East Asia Antimicrobial Resistance Diagnostics Market
        1. South East Asia Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. South East Asia Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. South East Asia Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      11. Rest of Asia-Pacific Antimicrobial Resistance Diagnostics Market
        1. Rest of Asia-Pacific Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Rest of Asia-Pacific Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Rest of Asia-Pacific Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
    4. Middle East and Africa
      1. Middle East and Africa Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      2. Middle East and Africa Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      3. Middle East and Africa Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
      4. UAE Antimicrobial Resistance Diagnostics Market
        1. UAE Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. UAE Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. UAE Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      5. Turkey Antimicrobial Resistance Diagnostics Market
        1. Turkey Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Turkey Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Turkey Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      6. Saudi Arabia Antimicrobial Resistance Diagnostics Market
        1. Saudi Arabia Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Saudi Arabia Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Saudi Arabia Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      7. South Africa Antimicrobial Resistance Diagnostics Market
        1. South Africa Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. South Africa Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. South Africa Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      8. Egypt Antimicrobial Resistance Diagnostics Market
        1. Egypt Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Egypt Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Egypt Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      9. Nigeria Antimicrobial Resistance Diagnostics Market
        1. Nigeria Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Nigeria Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Nigeria Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      10. Rest of MEA Antimicrobial Resistance Diagnostics Market
        1. Rest of MEA Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Rest of MEA Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Rest of MEA Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
    5. LATAM
      1. LATAM Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Microbial Culture
        2. Immunoassay
        3. Polymerase Chain Reaction
        4. Next-generation Sequencing
        5. Mass Spectrometry
        6. Others
      2. LATAM Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Methicillin-Resistant Staphylococcus Aureus 
        2. Drug-Resistant Streptococcus Pneumoniae
        3. Drug-Resistant Campylobacter
        4. Drug-Resistant Neisseria Gonorrhea
        5. Drug-Resistant Salmonella
        6. Others
      3. LATAM Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Pharmaceutical & Biotechnology Companies
        4. Others
      4. Brazil Antimicrobial Resistance Diagnostics Market
        1. Brazil Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Brazil Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Brazil Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      5. Mexico Antimicrobial Resistance Diagnostics Market
        1. Mexico Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Mexico Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Mexico Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      6. Argentina Antimicrobial Resistance Diagnostics Market
        1. Argentina Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Argentina Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Argentina Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      7. Chile Antimicrobial Resistance Diagnostics Market
        1. Chile Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Chile Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Chile Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      8. Colombia Antimicrobial Resistance Diagnostics Market
        1. Colombia Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Colombia Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Colombia Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
      9. Rest of LATAM Antimicrobial Resistance Diagnostics Market
        1. Rest of LATAM Antimicrobial Resistance Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Microbial Culture
          2. Immunoassay
          3. Polymerase Chain Reaction
          4. Next-generation Sequencing
          5. Mass Spectrometry
          6. Others
        2. Rest of LATAM Antimicrobial Resistance Diagnostics Market By Pathogen 2022-2034 (USD MILLION/ Units)
          1. Methicillin-Resistant Staphylococcus Aureus 
          2. Drug-Resistant Streptococcus Pneumoniae
          3. Drug-Resistant Campylobacter
          4. Drug-Resistant Neisseria Gonorrhea
          5. Drug-Resistant Salmonella
          6. Others
        3. Rest of LATAM Antimicrobial Resistance Diagnostics Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Diagnostic Laboratories
          3. Pharmaceutical & Biotechnology Companies
          4. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.